{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000347.1:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000347.1",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "Ala53Thr (A53T) variant"
        },
        {
          "HGVS": "NM_000347.1:c.140G>G",
          "cDNA Change": {
            "transcript": "NM_000347.1",
            "ref": "G",
            "alt": "G",
            "position": "140"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "G",
            "position": "47"
          },
          "Description in input context": "Gly47Gly (G47G) variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005035"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture overexpression",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells overexpressing α-synuclein variants were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Ala53Thr variant increased α-synuclein aggregation by 30% compared to wild-type."
        },
        {
          "Variant": "NM_000347.1:c.140G>G",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Gly47Gly variant showed no significant change in α-synuclein aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein aggregation ≤ 10% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein aggregation > 25% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Transgenic mouse model",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "SNCA A53T transgenic mice",
        "Description": "Transgenic mice expressing the A53T variant were used for behavioral and histological analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mice exhibited motor deficits and Lewy body-like inclusions in the brain."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Six mice per group were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type littermates were used as controls."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for behavioral data analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal motor function (rotarod latency ≥ 15 seconds).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal motor function (rotarod latency < 10 seconds).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "siRNA knockdown",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells with siRNA targeting SNCA were used to assess knockdown efficiency."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.158C>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "A53T variant expression was unaffected by siRNA knockdown."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Scrambled siRNA was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for knockdown efficiency analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "SNCA expression ≥ 50% of control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "SNCA expression < 30% of control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Protein aggregation assay",
      "Material used": {
        "Material Source": "Primary neurons",
        "Material Name": "Mouse midbrain neurons",
        "Description": "Primary neurons expressing α-synuclein variants were used to assess aggregation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T variant increased protein aggregation by 40% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent cultures were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type neurons were used as controls."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Aggregation ≤ 15% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation > 30% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "SNCA A53T transgenic mice",
        "Description": "Brain tissue from A53T transgenic mice was analyzed for Lewy body pathology."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mice exhibited Lewy body-like inclusions in the substantia nigra."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five mice per group were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type littermates were used as controls."
      },
      "Basic negative control": {
        "Basic negative控制": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used for pathological scoring."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lewy body score ≤ 1 (on a 0-4 scale).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Lewy body score ≥ 3 (on a 0-4 scale).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}